Strikingly, metastatic burden increased 100–1,000-fold between 3 and 15 dpi; the number of pulmonary HER2+ cells remained elevated even at 28 days, 60 days and 9 months after infection (Fig. 1b–d). Here, ERBB2 is linked to infection.